Danisch, S.* ; Slabik, C.* ; Cornelius, A.* ; Albanese, M. ; Tagawa, T. ; Chen, Y.-F. A. ; Krönke, N.* ; Eiz-Vesper, B.* ; Lienenklaus, S.* ; Bleich, A.* ; Theobald, S.J.* ; Schneider, A.* ; Ganser, A.* ; von Kaisenberg, C.* ; Zeidler, R. ; Hammerschmidt, W. ; Feuerhake, F.* ; Stripecke, R.*
Spatiotemporally skewed activation of PD-1 T cells after epstein barr virus infection and tumor development in long-term fully humanized mice.
Am. J. Pathol. 189, 521-539 (2019)
Humanized mice developing functional human T cells endogenously and capable of recognizing cognate human leukocyte antigen matched tumors are emerging as relevant models for studying human immuno-oncology in vivo. Herein, mice transplanted with human CD34(+) stem cells and bearing endogenously developed human T cells for >15 weeks were infected with an oncogenic recombinant Epstein-Barr virus (EBV), encoding enhanced firefly luciferase and green fluorescent protein. EBV firefly luciferase was detectable 1 week after infection by noninvasive optical imaging in the spleen, from where it spread rapidly and systemically. EBV infection resulted into a pronounced immunologic skewing regarding the expansion of CD8(+) T cells in the blood outnumbering the CD4(+) T and CD19(+) B cells. Furthermore, within 10 weeks of infections, mice developing EBV-induced tumors had significantly higher absolute numbers of CD8(+) T cells in lymphatic tissues than mice controlling tumor development. Tumor outgrowth was paralleled by an up regulation of the programmed cell death receptor 1 on CD8(+) and CD4(+) T cells, indicative for T-cell dysfunction. Histopathological examinations and in situ hybridizations for EBV in tumors, spleen, liver, and kidney revealed foci of EBV-infected cells in perivascular regions in close association with programmed cell death receptor 1 positive infiltrating lymphocytes. The strong spatiotemporal correlation between tumor development and the T-cell dysfunctional status seen in this viral oncogenesis humanized model replicates observations obtained in the clinical setting.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Immune-responses; Ebv; Reconstitution; Expression; Model; System; Chain; Stem
Keywords plus
Language
Publication Year
2019
Prepublished in Year
2018
HGF-reported in Year
2018
ISSN (print) / ISBN
0002-9440
e-ISSN
1525-2191
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 189,
Issue: 3,
Pages: 521-539
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-001
G-501501-001
Grants
Copyright
Erfassungsdatum
2019-01-14